BIOVIE INC (BIVI) Stock Income Statement
NASDAQ:BIVI • US09074F5044
Current stock price
1.45 USD
+0.04 (+2.84%)
Last:
| TTM (2025-12-31) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 17.56M | 17.60M | 32.18M | 45.08M | 27.25M | |||
| Research and Development | 9.78M | 9.27M | 23.10M | 33.30M | 17.26M | |||
| Selling, General, and Administrative Expenses | 7.55M | 8.10M | 8.86M | 11.55M | 9.77M | |||
| Operating Income | -17.56M | -17.60M | -32.18M | -45.08M | -27.25M | |||
| Interest Income/Expense | 763.50K | 524.10K | 59.10K | -5.18M | 1.17M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | -639.00K | -468.00K | 5.20K | N/A | 0.00 | |||
| Income Before Taxes | -17.43M | -17.54M | -32.12M | -50.26M | -26.08M | |||
| Net Income | -17.48M | -17.91M | -33.01M | -50.26M | -26.08M | |||
| EBITDA | -17.33M | -17.37M | -31.96M | -44.85M | -27.02M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.13 | -12.12 | -73.05 | -154.72 | -105.74 | |||
| Non GAAP EPS | N/A | N/A | N/A | -156.00 | N/A | |||
| Statistics | ||||||||
All data in USD